Pharmaceutical Glass Packaging Market Size to Worth USD 41.92 Bn by 2032

The global pharmaceutical glass packaging market size is calculated at USD 21.27 billion in 2024 and is expected to be worth around USD 41.92 billion by 2032, growing at a CAGR of 8.8% from 2024 to 2032.

Ottawa, May 14, 2024 (GLOBE NEWSWIRE) — The global pharmaceutical glass packaging market size was estimated at USD 19.62 billion in 2023 and is predicted to hit around USD 38.38 billion by 2031, a study published by Towards Packaging a sister firm of Precedence Research.

Report Highlights: Important Revelations

  • Expansion of pharmaceutical glass packaging in North America.
  • Swift growth of the pharmaceutical glass packaging market in Asia-Pacific.
  • Flexibility and significance of pharmaceutical glass vials.
  • Securing access to effective medical care through the importance of glass packaging for generic drugs.
  • Increasing demand for pharmaceutical glass packaging driven by the expansion of distribution channels.

Download a free sample of our comprehensive analysis on the Pharmaceutical Glass Packaging Market at: https://www.towardspackaging.com/personalized-scope/5161

Glass has long been the main material used in the pharmaceutical packaging industry because of its remarkable qualities. Glass is a great material to store drugs in solid, liquid, injectable, or reconstitution form because of its chemical stability and inertness. The medications’ purity and integrity are guaranteed to last due to its non-reactive nature, even in the presence of other compounds or chemicals. Glass also has a strong resilience to temperature changes, which is important in the pharmaceutical industry because pharmaceutical items frequently need certain storage conditions. This resilience is especially useful for preserving the integrity of the packaging during procedures like sterilisation, freezing, or freeze-drying.

Amber-coloured pharmaceutical glass can be developed to reduce light transmission, which makes it appropriate for pharmaceuticals that are sensitive to light. Packaging businesses usually buy glass tubes and use them to make the finished product. When it comes to make these tubes into vials, heat processing is applied, which entails heating, cutting, and shaping the vials’ shoulders, mouths, and bases. The vials then go through an annealing furnace, which lowers the stress created during the moulding process.

If You Have Any Questions, Please Feel Free to Contact Us at @ sales@towardspackaging.com

Glass vials with tubular shapes that are thin, transparent, and have a consistent surface are especially well-suited for freeze-drying processes. A increasing trend in pharmaceutical packaging is also the use of recycled glass, with speciality goods meeting the needs of particular types of glass needed for pharmaceutical applications. To complete the material’s lifecycle, recycling entails using chemical and mechanical procedures to recreate the glass powder. In parallel, efforts are being made to create low-emission furnaces with innovative technologies in an attempt to reduce the impact that glass manufacture has on the environment.

Glass is still widely used in pharmaceutical packaging because of its natural qualities of chemical stability, temperature resistance, and inertness. The glass sector is seeing improvements in environmental sustainability and recycling techniques, which ensures glass’s continuous existence as the material of choice for pharmaceutical packaging.

Get a customized report tailored to your specific needs and requirements based on our in-depth analysis of the Pharmaceutical Glass Packaging Market: https://www.towardspackaging.com/customization/5161

For Instance,

  • In January 2024, the leader in global packaging, TricorBraun, announced the company has purchased Glassland, a supplier of glass packaging. Through the acquisition, TricorBraun’s premium glass packaging division, Vetroelite, expands its base in Germany and increases its overall European reach.

Pharmaceutical Glass Packaging Market Trends

  • Glass packaging for pharmaceuticals is still the favoured option since it can keep drugs stable and intact throughout time. Glass has good barrier qualities that shield drugs from air, moisture, and other elements that can reduce their effectiveness.
  • There is an increasing trend for specialised glass containers adapted to specific pharmaceutical applications and formulas.
  • Superior strength, purity, and chemical resistance in glass materials are becoming more and more important to pharmaceutical industries.
  • The pharmaceutical glass packaging industry is embracing eco-friendly packaging materials and processes due to sustainability concerns.

Growth of Pharmaceutical Glass Packaging in North America

The pharmaceutical glass packaging market in North America is expanding significantly due to a number of factors, including regulatory requirements, growing demand for pharmaceutical products, and technical improvements. The two main nations fostering this expansion in the area are the United States and Canada.

The United States’ pharmaceutical glass packaging market is expanding due to a number of causes, including the ageing population, rising healthcare costs, and the incidence of chronic diseases. Pharmaceutical businesses package a wide range of pharmaceutical items in glass containers, such as injectable drugs, oral solid pills, liquid formulations, and biologics.” Because of its chemical stability, inert qualities, and ability to maintain medication potency for extended periods of time, glass is preferred. This has caused pharmaceutical companies in the US to gradually switch to glass packaging, with a focus on patient safety and product integrity.

The Canadian pharmaceutical glass packaging sector is growing due to similar considerations. Strict regulatory requirements that guarantee the safety and quality of medicines define the nation’s pharmaceutical sector. Because it can prevent contamination, preserve product sterility, and safeguard the effectiveness of medications, glass packaging is recommended. Moreover, the growing demand for biologics, customised drugs, and specialty pharmaceuticals is propelling the adoption of glass packaging solutions tailored to particular formulations and delivery modalities.

Pharmaceutical glass packaging finds application outside traditional medicine methods of distribution in North America, the pharmaceutical industry’s top-performing region. The packaging of diagnostics, laboratory reagents, and biopharmaceuticals is also included in this industry. Developments in technology within the glass manufacturing industry have enabled the production of novel packaging solutions, such as ampoules, cartridges, vials, and prefillable syringes, which cater to the evolving needs of the pharmaceutical business.

Future growth in North America’s pharmaceutical glass packaging market is anticipated due to factors like increased healthcare expenses, advancements in drug delivery technology, and a focus on patient-centred care. It is expected that the region would maintain its prominent position in the worldwide pharmaceutical glass packaging industry with additional improvements and expenditures in research and development.

For Instance,

  • In November 2023, The Ardagh Group’s operating subsidiary, Ardagh Glass Packaging-North America, has added two additional Boston Round bottles to its expanding line of American-made bottles.

Rapid Expansion of the Pharmaceutical Glass Packaging Market in Asia-Pacific

The pharmaceutical glass packaging market in Asia Pacific is growing at a fast pace owing to some significant factors. In China, India, Japan, South Korea and Australia, the pharmaceutical industries are increasing which result into high demand of glass packaging solutions.

China being the biggest exporter of glasses and glassware’s has its application everywhere. China and India, two of the largest pharmaceutical markets in the region are experiencing rapid increase in both drug production and consumption. In 2022, India exported glass worth $329.68 million to US. Several forces drive the need for pharmaceuticals made from glass in these countries such as population growth, rising healthcare costs and government efforts to improve health facilities. Pharmaceutical products including injectables, vaccines biologics and oral drugs use glass packaging.

For Instance,

  • In March 2023, Amber pharmaceutical glass manufacture was started by SCHOTT in India in response to growing demand. A calculated step expands the options for borosilicate glass that pharmaceutical packaging producers in Asia and India can choose from.

Japan’s high-end pharmaceutical packaging solutions are highly sought after due to its burgeoning medical industry as well as an aging citizenry. Combined with Japan’s $235.56 billion-worth drug markets is that of China. Glass packaging is better for preserving medication stability and integrity; this especially it applies to light-sensitive formulas that are delicate.

The rapid growth of the Asia-Pacific pharmaceutical glass packaging market is caused by factors such as pharmaceutical manufacturing operations, increasing demand for specialty pharmaceuticals and expanding healthcare infrastructure. The region is projected to be a significant development driver for the global pharmaceutical glass packaging market in light of continued expenditure on pharmaceuticals and healthcare.

For Instance,

  • In September 2023, Orora, an Australian packaging company, has stated that it has begun negotiations to acquire all of Saverglass, a French manufacturer of premium glass bottles.

Pharmaceutical Glass Packaging Market, DRO

Demand:

  • Pharmaceutical products’ safety, effectiveness, and integrity can be preserved by using pharmaceutical glass packaging, which is the preferred choice. Glass containers offer a non-reactive and inert barrier that shields medications from outside elements including light, moisture, air, and contamination, preserving the stability and shelf life of the product.

Restraint:

  • Pharmaceutical glass packaging can be more costly than alternative packaging materials like plastics or polymers, especially if it uses premium borosilicate glass.

Opportunity:

  • The pharmaceutical business may improve product performance, functionality, and user experience by utilising innovations in glass packaging technologies.

Versatility and Importance of Pharmaceutical Glass Vials

Pharmaceutical glass vials are available in different sizes and designs, suitable for different pharmaceutical uses including storing liquids, powders or capsules. These bottles can be made from either amber or clear glass. Clear glass vials perform well for many medications because they allow for high UV penetration; on the other hand, when it comes to light sensitive drugs such as those that undergo degradation by exposure, amber glass vial is the preferable choice. These glasses absorb the higher-energy region of the visible spectrum thereby minimizing damage from light which slows down the decomposition of drugs recommended.

Glass vials used in pharmaceuticals are very versatile with several compositions and storage requirements. These containers ensure secure packing of medicines whether they come in form of liquids, powders or pellets. Therefore, there is no need to worry about searching for the best option since these products have a wide range of sizes and shapes making them more efficient at utilizing space and less wasteful.

The choice between clear and amber glass vials has a bearing on the stability as well as efficacy of drugs throughout their shelf life. More security is provided by amber bottles.

For Instance,

  • In February 2024, A new siliconization service was introduced by the pharmaceutical packaging company SGD Pharma at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant in northern France. With the most recent advancement, the business expands its internal services, particularly in the vial size section.

Ensuring Access to Secure and Efficient Medical Care with Importance of Glass Packaging for Generic Drugs

Generic drugs are pharmaceuticals sold under their chemical or generic name even if they are bioequivalent to the brand name medication. Some of these pharmaceuticals can be manufactured and marketed at a lower cost by some pharmaceutical companies because they are produced after the patent exclusivity of the original brand-name medication has expired. Glass packaging is frequently utilized in the pharmaceutical industry for generic medications due to many reasons.

The glass packaging ensures generic drugs’ safety and integrity over their shelf life by acting as an excellent barrier against contamination and degradation. It prevents interactions between drugs with its inert nature hence, the potency of the medicine is preserved. The glass container as well protects against light, air and moisture that may ultimately damage some drugs.

A variety of therapeutic classes including cardiovascular, anti-infective, central nervous system, and respiratory treatments use glass vials, ampoules or bottles to package generics in. To this effect, oral medications, intravenous solutions among others have to rely on dependable and long-lasting containers that preserve effectiveness and purity over time.

For Instance,

  • In August 2021, Leading vaccine manufacturer Serum Institute of India has bought a 50% share in pharmaceutical packaging company Schott Kaisha with the aim to form a joint venture with Schott AG, a specialty glass company in Germany.

Expanding Distribution Channels Propel Demand for Pharmaceutical Glass Packaging

The growth of distribution channels, particularly pharmacies, is the main factor driving the market for prescription glass packaging. Considering the goal to render it simpler for prescription medications packaged in glass containers to be distributed and dispensed, pharmacies are essential intermediary between end users and pharmaceutical manufacturers. Because more pharmacies—both conventional physical shops and internet merchants-are opening up, there is a growing need for pharmaceutical glass packaging. As more pharmacies open, there is an increasing need for a trustworthy and efficient packaging solution for the safe storage and dispensing of medications. Glass containers ensure the long-term viability and quality of the pharmaceuticals by offering the best protection against light, moisture, and contamination. There is less potential for chemical reactions that might decrease the potency and efficacy of the medication since glass is inert and does not react with medications.

Glass packaging increases product visibility so that consumers and chemists may conveniently evaluate its contents. Pharmaceutical glass packaging is in higher demand as specialty pharmacies that fill costly and challenging prescriptions proliferate. For certain medications, glass containers are an excellent choice because their stability and efficacy often require special packing methods. Pharmacies are adopting sustainable methods and friendly materials for packaging like glass at an increasing pace. Glass is eco-friendly and reusable, which makes it consistent with the sustainability goals of many pharmaceutical companies and pharmacies. The rise of distribution channels, primarily pharmacies, favours the expansion of the pharmaceutical glass packaging market by creating a strong requirement for trustworthy and better packaging solutions to meet the demands of the developing healthcare industry.

For Instance,

  • In March 2024, A new technology to automate patients’ medicine packaging has been launched by Capsa Healthcare, a global provider of workflow solutions for the healthcare industry.

Established Industry Giants and Emerging Players in Pharmaceutical Glass Packaging Market

The competitive landscape of the pharmaceutical glass packaging market is dominated by established industry giants such as Amcor plc, Bormioli Pharma, SGD Pharma, Gerresheimer AG, Becton, Dickinson, and Company, AptarGroup, Inc., Drug Plastics Group, Schott AG, Owens Illinois, Inc., West Pharmaceutical Services, Inc., Berry Global, Inc., WestRock Company, International Paper, Comar, LLC, CCL Industries, Inc., Vetter Pharma International, Corning Inc., Nipro Corporation, Stölzle-Oberglas GmbH, , Shandong Medicinal Glass Co., Ltd., Beatson Clark, and ÅžiÅŸecam Group. These giants compete with upstart direct-to-consumer firms that use digital platforms to gain market share. Key competitive characteristics include product innovation, sustainable practices, and the ability to respond to changing consumer tastes.

Amcor is a pharmaceutical glass packaging company that prioritises sustainability and innovation. They make research and development investments to provide innovative packaging solutions that satisfy the changing demands of pharmaceutical firms. Sustainability is given top priority by using environmentally friendly raw materials and production techniques.

For Instance,

  • In August 2023, Amcor, a leader in the development and production of sustainable packaging solutions worldwide, said today that it has reached a deal to buy Phoenix Flexibles, increasing its presence in the rapidly expanding Indian market.

High-quality glass packaging solutions designed especially for the pharmaceutical industry are Bormioli Pharma’s area of expertise. Offering a wide variety of cutting-edge, adaptable packaging alternatives that guarantee the security, integrity, and compliance of pharmaceutical products throughout their lifecycle is the core of their business approach.

For Instance,

  • In March 2022, Bormioli Pharma, a leading global provider of integrated packaging solutions for injectable pharmaceuticals, reported strong growth in its North American business, with sales rising by more than 40% year over year.

SGD Pharma is committed to providing the pharmaceutical industry with high-end glass packaging solutions. Utilising state-of-the-art technology and strict quality control procedures, their approach creates pharmaceutical-grade glass containers that satisfy the most exacting requirements for dependability, purity, and durability.

For Instance,

  • In June 2023, Corning Incorporated and SGD Pharma announced a collaborative venture that will enable SGD Pharma to use Corning’s Velocity® Vial technology platform and will see the development of a new glass tubing facility to boost pharmaceutical manufacturing in India.

Gerresheimer AG is dedicated to being the world’s foremost supplier of glass packaging solutions for pharmaceuticals. Their approach consists of ongoing investments in innovative production facilities as well as substantial R&D activities. 

For Instance,

  • In February 2023, Gerresheimer AG, an established worldwide supplier of drug delivery systems for pharmaceuticals, biotechnology, and cosmetics as well as healthcare and beauty products, announced a joint venture with Corning Incorporated, a pioneer in the fields of manufacturing and materials research. The agreement aims to increase the Velocity® Vial technology platform’s worldwide availability.

Browse More Insights of Towards Packaging:

  • The compostable packaging market size forecasted to expand from USD 88.73 billion in 2022 is estimated to reach USD 197.85 billion by 2032, expanding at a CAGR of 8.4% between 2023 and 2032.
  • The snacks packaging market size is presumed to grow from USD 17.82 billion in 2022 to acquire a anticipated USD 28.07 billion by 2032, growing at a CAGR of 4.7% between 2023 and 2032.
  • The tea packaging market size is envisioned to advance from USD 5.92 billion in 2022 to secure a forecasted USD 9.32 billion by 2032, growing at a 4.7% CAGR between 2023 and 2032.
  • The sustainable packaging market size is predicted to climb from USD 260.21 billion in 2022 to obtain a projected USD 490.73 billion by 2032, growing at a 6.6% CAGR between 2023 and 2032.
  • The luxury packaging market size is expected to increase from USD 15.30 billion in 2022 to attain a calculated USD 25.27 billion by 2032, growing at a 5.2% CAGR between 2023 and 2032.
  • The meat packaging market size is anticipated to rise from USD 13.48 billion in 2022 to achieve an approximation of USD 22.28 billion by 2032, growing at a 5.2% CAGR between 2023 and 2032.
  • The packaging machinery market size forecasted to expand from $46.10 billion in 2022 is estimated to reach $75.45 billion by 2032, growing at a 5.1% CAGR between 2023 and 2032.
  • The global beer packaging market size is predicted to climb from USD 23.84 billion in 2022 to attain a calculated USD 36.14 billion by 2032, growing at a 4.3% CAGR between 2023 and 2032.
  • The fragrance packaging market size is presumed to grow from USD 2.14 billion in 2022 to reach a conjectured USD 3.33 billion by 2032, growing at a 4.6% CAGR between 2023 and 2032.
  • The global compostable flexible packaging market size is predicted to climb from USD 1.2 billion in 2022 to attain a calculated USD 2.11 billion by 2032, growing at a 5.9% CAGR between 2023 and 2032.

Pharmaceutical Glass Packaging Market Player

Pharmaceutical glass packaging leading market players are Amcor plc, Becton, Dickinson, and Company, AptarGroup, Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, Owens Illinois, Inc., West Pharmaceutical Services, Inc., Berry Global, Inc., WestRock Company, SGD Pharma, International Paper, Comar, LLC, CCL Industries, Inc., Vetter Pharma International, Corning Inc., Nipro Corporation, Stölzle-Oberglas GmbH, Bormioli Pharma, Shandong Medicinal Glass Co., Ltd., Beatson Clark, and ÅžiÅŸecam Group.

Market Segments

By Packaging Type

  • Vials
  • Bottles
  • Ampoules
  • Syringe
  • Cartridges

By Drug Type

  • Generic
  • Biologic
  • Branded

By Distribution Channel

  • Pharmacies
  • Hospitals
  • Clinics
  • Wholesalers and Distributors
  • Others

By Region

  • North America
  • Asia Pacific
  • Europe
  • LAMEA

Get ahead of your competitors with our in-depth analysis of the Pharmaceutical Glass Packaging Market. Secure your copy now @ https://www.towardspackaging.com/price/5161

Get the latest insights on packaging industry segmentation with our Annual Membership. Subscribe now for access to detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead in the dynamic packaging sector with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunitiesSubscribe to Annual Membership

If you have any questions, please feel free to contact us at sales@towardspackaging.com

About Us

Towards Packaging is a leading global consulting firm specializing in providing comprehensive and strategic research solutions. With a highly skilled and experienced consultant team, we offer a wide range of services designed to empower businesses with valuable insights and actionable recommendations. We stay abreast of the latest industry trends and emerging markets to provide our clients with an unrivalled understanding of their respective sectors. We adhere to rigorous research methodologies, combining primary and secondary research to ensure accuracy and reliability. Our data-driven approach and advanced analytics enable us to unearth actionable insights and make informed recommendations. We are committed to delivering excellence in all our endeavours. Our dedication to quality and continuous improvement has earned us the trust and loyalty of clients worldwide.

Browse our Brand-New Journal:

https://www.towardshealthcare.com/

https://www.towardsautomotive.com/

https://www.precedenceresearch.com/

For Latest Update Follow Us: https://www.linkedin.com/company/towards-packaging/

Get Our Freshly Printed Chronicle: https://www.packagingwebwire.com/

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy